HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News Briefs: CSC Petition, Shiseido In India, Inter Parfums S&E, More

This article was originally published in The Rose Sheet

Executive Summary

Walgreens should eliminate formaldehyde releaser quaternium-15 from its private-label baby-care products, according to the Campaign for Safe Cosmetics, which is working to rally consumers. More news in brief.

You may also be interested in...

Walmart Program Seeks Greener Beauty, Greater Supplier Transparency

Walmart aims to reduce or eliminate high-priority toxins from its beauty offering with a program announced Sept. 12. The Campaign for Safe Cosmetics celebrates the move and calls on Target to implement a similar safe-cosmetics policy in its stores.

Walgreens Launches Ology Personal Care Without “Harmful Chemicals”

Drugstore chain’s new line features “plant- and mineral-based” ingredients, carries an endorsement from Healthy Child Healthy World and is affordably priced. In promoting all that Ology is free of – including sulfates, parabens and phthalates – Walgreens suggests that better regulations are needed in the U.S. to ensure that consumers aren’t being exposed to “harmful chemicals.”

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts